In this section you'll find photographic features that explore holidays and photography courses, details about members meetings, trials and tribulations of installing new software along with general ...

Dividend stocks have more than doubled up the annualized return of non-payers over the last 51 years. Though high-yield stocks can be risky, some supercharged dividend payers are true gems. Three time ...

Certificates of deposit with 2-year maturities promise an average 1.47% rate of return, the latest government data show. Not great. The good news? Some banks and credit unions are touting ...

Iberdrola (IBDRF) (OTCPK:IBDRY) bought a 30.29% stake in its Brazilian subsidiary Neoenergia from the Brazilian pension fund Previ for ~$2.2 billion. This deal lifts Iberdrola's ownership in ...

More than 74.5 million people receive Social Security benefits, according to the Social Security Administration (SSA). Many of them rely on Social Security for their financial well-being. For some ...

Premier Inc. has agreed to be acquired by healthcare-focused investment firm Patient Square Capital in a deal that values the provider of healthcare improvement solutions at about $2.6 billion.

The automaker is also expanding its electrified lineup, including new hybrids and extended-range EVs. The automaker is also expanding its electrified lineup, including new hybrids and extended-range ...

Sept 22 (Reuters) - Compass (COMP.N), opens new tab, the largest U.S. residential real estate broker, is set to buy Anywhere Real Estate (HOUS.N), opens new tab in a deal valued at $4.2 billion, as it ...

This is read by an automated voice. Please report any issues or inconsistencies here. A Times review of the Trump administration’s settlement proposal to UCLA lays out sweeping demands on numerous ...

Compass, the largest U.S. residential real estate broker, is set to buy Anywhere Real Estate in a deal valued at $4.2 billion, adding heft at a time when home sales are softening as buyers remain ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...